Molecular immunopathogenesis of HIV infection

Genitourinary Medicine

Volumn 72, Issue 6, 1996, Pages 408-418

  Ng, T T C ^a   Pinching, A J ^a   Guntermann, C ^a   Morrow, W J W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE;

APOPTOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 79960421298     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.72.6.408     Document Type: Review

References (173)

1. Garry RF. Potential mechanisms for the cytopathic properties of HIV. AIDS 1989;3:683-94.
2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:-123-6.
3. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-6.
4. Shearer GM, Clerici M. Early T-helper cell defects in HIV infection. AIDS 1991;5:245-53.
5. Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ. Detection of human immunodeficiency virus type I provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med 1992;326:1385-91.
6. Finkel TH, Tudor-Williams G, Banda NK. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. J Cell Biochem 1995;Suppl 21B:182 (Abstract D4-007).
7. Finkel TH, Banda NK. Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells? Curr Opin Immunol 1994;6:605-15.
8. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
9. Hyjek E, Lischner HW, Hyslop T. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol 1995;155:4060-71.
10. Maggi E, Mazzetti M, Ravina A, Annunziato F, de Carli M, Piccinni MP, et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994;265:244-8.
11. Meyaard L, Otto SA, Keet PM, van Lier RAW, Miedema F. Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection. Blood 1994;12:4262-8.
12. Prete GD, Maggi E, Pizzolo G, Romagnani S. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995;16:76-8.
13. + T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood 1992;79:1746-53.
14. - T helper cells from normal donors and HIV-infected patients. J Immunol 1995;154: 1408-17.
15. Serfling E, Barthelmas R, Pfeuffer I, Schenk B, Zarius S, Swoboda R, et al. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J 1989;8:465-73.
16. Rooney JW, Hodge MR, McCaffrey PG, Rao A, Glimcher LH. A common factor regulates both Th1-and Th2-specific cytokine gene expression. EMBO J 1994;13:625-33.
17. Roebuck KA, Gu DS, Kagnoff MF. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS 1996;10:819-26.
18. Ruegg CL, Strand M. A synthetic peptide with sequence identity to the transmembrane protein gp41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx. Cell Immunol 1991;137:1-13.
19. Ruegg CL, Strand M. Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41. J Immunol 1990;144:3928-35.
20. Hofmann B, Nishanian P, Nguyen T, Insixiengmay P, Fahey JL. Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc Natl Acad Sci 1993;90:6676-80.
21. Greenway A, Azad A, McPhee D. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J Virol 1995;69:1842-50.
22. Niederman TMJ, Randall-Hastings W, Luria S, Bandres JC, Ratner L. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology 1993;194:338-44.
23. Gazzinelli RT, Bala S, Stevens R, Stevens R, Baseler M, Wahl L, et al. HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. J Immunol 1995;155:1565-14.
24. Biggs BA, Hewish M, Kent S, Hayes K, Crowe SM. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J Immunol 1995;154:6132-9.
25. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implication in tissue kinetics. Br J Cancer 1972;26:239-57.
26. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic culture. Nature 1989;337:181-41.
27. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed cell death of T cells in HIV-1 infection. Science 1992;257:217-9.
28. Wang ZQ, Orlikowsky T, Dudhane A, Mittler R, Blum M, Lacy E, Riethmüller G, Hoffmann MK. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients. Eur J Immunol 1994;24:1553-7.
29. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, et al. Crosslinking CD4 by Human Immunodeficiency Virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992;176:1099-106.
30. Nardelli B, Gonzalez CJ, Schechter M, Valentine FT. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc Natl Acad Sci USA 1995;92:7312-6.
31. Swain SL, Bradley LM. Helper T cell memory: more questions than answers. Semin Immunol 1992;4:59-68.
32. Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virusinfected asymptomatic individuals. J Exp Med 1992;175:331-40.
33. Kroon FP, van Dissel JT, de Jong JC, van Furth R. Antibody responses to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994;8:469-76.
34. Meyaard L, Otto SA, Keet JPM, Roos MTL, Miedma F. Programmed cell death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J Clin Invest 1994;93:982-8.
35. Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoisier M, Goujard C, et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons. J Immunol 1996;156:3509-20.
36. Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, et al. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 1994;91:11811-5.
37. Estaquier J, Idziorek T, Zou W, Emilie D, Farber CM, Bourez JM, et al. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995;182:1759-67.
38. Vyakarnam A, Matear PM, Griffiths G, Bruisten S, Huisman H. Heterogeneity in CD4+ IL-4 producing clones measured in terms of cytokine profile, cell death and HIV replication. MRC AIDS Research Workshop, Manchester, UK, 1995. (Abstract L7)
39. Ng TTC, Kanner S, Humphries M, Nye K, Anderson J, Khoo S, et al. HIV-mediated blockade of the integrin-triggered cell survival signal which rescues T lymphocyte apoptosis. XIth International Conference on AIDS, Vancouver (July, 1996).
40. Ameisen JC, Estaquier J, Idziorek T, De Bels F. Programmed cell death and AIDS pathogenesis: significance and potential mechanisms. Curr Top Microbiol Immunol 1995;200:195-211.
41. McConkey DJ, Orrenius S, Jondal M. Cellular signalling in programmed cell death (apoptosis). Immunol Today 1990;11:120-1.
42. Kabelitz D, Pohl T, Pechhold K. T cell apoptosis triggered via the CD3/T cell receptor complex and alternative activation pathways. Curr Top Microbiol Immunol 1995;200:1-14.
43. Levine BL, Mosca JD, Riley JL, Carroll RG, Vahey MT, Jagodzinski LL, et al. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 1996;272:1939-43.
44. Tuosto L, Piazza C, Moretti S, Modesti A, Greenlaw R, Lechler R, et al. Ligation of either CD2 or CD28 rescues CD4+ T cells from HTV-gp120-induced apoptosis. Eur J Immunol 1995;25:2917-22.
45. Ng TTC, Humphries MJ, Kanner SB, Anderson J, Nye KE, Khoo S, Morrow WJW. HIV-induced defects in integrin-mediated signaling cascades: implications for pathogenesis. Ninth Annual AIDS Research Workshop, Manchester, UK, 1995. (Abstract 129)
46. Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS, the programmed cell death hypothesis. Immunol Today 1991;12:102-5.
47. Ng TTC, Guntermann C, Nye KE, Parkin JM, Anderson J, Norman JE, Morrow WJW. Adhesion co-receptor expression and intracellular signalling in HIV disease: implications for immunotherapy. AIDS 1995;9:337-43.
48. Guo MML, Hildreth JEK. HIV-induced loss of CD44 expression in monocytic cell lines. J Immunol 1993;151:2225-36.
49. Eales LJ, Farrant J, Helbert M, Pinching AJ. Peripheral blood dendritic cells in persons with AIDS-related complex: loss of high intensity class II antigen expression and function. Clin Exp Immunol 1988;71:423-7.
50. Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 1990;71:38-45.
51. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995;377:348-51.
52. Nye KE, Pinching AJ. HIV infection of H9 lymphoblastoid cells chronically activates the inositol polyphosphate pathway. AIDS 1990;4:41-5.
53. Pinching AJ. Immunological consequences of human immunodeficiency virus infection. Rev Med Microbiol 1990;1:83-91.
54. Pinching AJ, Nye KE. Defective signal transduction - a common pathway for cellular dysfunction in HIV infection? Immunol Today 1990;11:256-9.
55. Pinching AJ. HIV/AIDS pathogenesis and treatment: new twists and turns. Curr Opin Immunol 1991;3:537-42.
56. McConkey DJ, Hartzell P, Amador-Perez JF, Orrenius S, Jondal M. Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol 1989;143:1801 -6.
57. Luciw PA, Shacklett BL. Molecular biology of the human and simian immunodeficiency viruses. In: Morrow WJW, Haigwood NL, eds. HIV Molecular Organization, Pathogenicity and Treatment. Amsterdam, Elsevier 1993:123-219.
58. Jabado N, Le Deist F, Fischer A, Hivroz C. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-κB and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. Eur J Immunol 1994;24:2646-52.
59. Chirmule N, Kalyanaraman VS, Oyaizu N, Slade HB, Pahwa S. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein gp120 of human immunodeficiency virus. Blood 1990;75:152-9.
60. Romano MF, Lamberti A, Petrella A, Bisogni R, Tassone P, Formisano S, et al. IL-10 inhibits nuclear factor-κB/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. J Immunol 1996;156:2119-23.
61. Niederman TMJ, Garcia JV, Hastings WR, Luria S, Ratner L. Human immunodeficiency virus type 1 Nef protein inhibits NF-κB induction in human T cells. J Virol 1992;66:6213-9.
62. Luria S, Chambers I, Berg P. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci USA 1991;88:5326-30.
63. Niederman TMJ, Hastings WR, Luria S, Bandres JC, Ratner L. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology 1993;194:338-44.
64. Greenway AL, McPhee DA, Grgacic E, Hewish D, Lucantoni A, Macreadie I, et al. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4-3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Virology 1994;198:245-56.
65. Aitken C, Konner J, Landau NR, Lenburg ME, Trono D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994;76:853-64.
66. Harris M. Myristoylation-dependent interactions between Nef and cellular proteins. Ninth Annual AIDS Research Workshop, Manchester, UK, 1995. (Abstract 148)
67. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-91.
68. Willard-Gallo KE, Wolinsky SM, Patterson BK. Decreased T cell receptor (TCR)/CD3 surface expression on HIV-1 infected T cells is correlated with an increase in tat regulated transcriptional activity. J Cell Biochem 1995;Suppl 21B:229 (Abstract D4-356).
69. Viscidi RP, Mayur K, Lederman HM, Frankel AD. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 1989;246:1606-8.
70. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. J Immunol 1996;156:1638-45.
71. Vogel BE, Lee SJ, Hildebrand A, Craig W, Pierschbacher MD, Wong-Staal F, et al. A novel integrin specificity exemplified by binding of the V5 integrin to the basic domain of the HIV Tat protein and vitronectin. J Cell Biol 1993;121:461-8.
72. Rosenblatt JD, Miles S, Gasson JC, Prager D. Transactivation of cellular genes by human retroviruses. Curr Top Microbiol Immunol 1995;193:25-49.
73. Garza Jr HH, Prakash O, Carr DJJ. Aberrent regulation of cytokines in HIV-1 TAT72-transgenic mice. J Immunol 1996;156:3631-7.
74. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995;268:429-31.
75. Patterson S, Knight SC. Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol 1987;68:1177-81.
76. Gabrilovich DI, Woods GM, Patterson S, Harvey JJ, Knight SC. Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules. Immunology 1994;82:82-7.
77. Macatonia S, Gompels M, Pinching AJ, Patterson S, Knight SC. Antigen presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology 1992;75:576-81.
78. Patterson S, English N, Helbert M, Pinching AJ, Knight SC. The effect of AZT on dendritic cell number and provirus load in peripheral blood of AIDS patients. MRC AIDS Research Workshop, Manchester, UK, 1995. (Abstract 72)
79. Frankel SS, Wenig BM, Burke AP, Mannan P, Thompson LDR, Abbondanzo SL, et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 1996;272:115-7.
80. Knight SC. A problem of antigen presentation. Curr Biol 1994;4:1131-4.
81. Weissman D, Li Y, Orenstein JM, Fauci AS. Both a precursor and a mature population of dendritic cells can bind HIV. J Immunol 1995;155:4111-7.
82. Borthwick NJ, Bofill M, Gombert WM, Akbar AN, Medina E, Sagawa K, et al. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS 1994;8:431-42.
83. Pantaleo G, Graziosi C, Butini L, Fauci AS. Role of CD8+ T lymphocytes in the pathogenesis of HIV infection. In: G Janossy, B Autran, F Miedema, eds. Immunodeficiency in HIV Infection and AIDS. Basel, Karger 1992:211-8.
84. Connick E, Schooley RT. HIV-1 specific immune responses. In: Morrow WJW, Haigwood NL, eds. HIV Molecular Organization, Pathogenicity and Treatment. Amsterdam, Elsevier 1993:75-97.
85. Gajewski TF, Renauld JC, Pel AV, Boon T. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J Immunol 1995;154:5617-48.
86. Starling GC, McLellan AD, Egner W, Sorg RV, Fawcett J, Simmons DL, et al. Intercellular adhesion molecule-3 is the predominant co-stimulatory ligand for leukocyte function antigen-1 on human blood dendritic cells. Eur J Immunol 1995;25:2528-32.
87. Hildreth JEK, Gotch FM, Hildreth PDK, McMichael AJ. A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur J Immunol 1983;13:202-7.
88. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
89. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-61.
90. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
91. Tenner-Racz K, Racz P, Bofill M, Schulz-Meyer A, Dietrich M, Kern P, et al. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol 1986;123:9-15.
92. Heath SL, Tew JG, Tew JG, Szakai AK, Burton GF. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 1995;377:740-4.
93. Koopman G, Pals ST. Cellular interactions in the germinal center: role of adhesion receptors and significance for the pathogenesis of AIDS and malignant lymphoma. Immunol Rev 1992;126:21-45.
94. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328:327-35.
95. Collins TL, Kassner PD, Bierer BE, Burakoff SJ. Adhesion receptors in lymphocyte activation. Curr Opin Immunol 1994;6:385-93.
96. Kalter DC, Gendelman HE, Meltzer MS. Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules. Immunol Lett 1991;30:219-28.
97. Hildreth JEK, Orentas RJ. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 1989;244:1075-8.
98. Vermot-Desroches C, Rigal D, Escaich S, Bernaud J, Pichoud C, Lamelin JP, Trepo C. Functional epitope analysis of the human CD11a/CD18 molecule (LFA-1, Lymphocyte function-associated antigen 1) involved in HIV-1 induced syncytium formation. Scand J Immunol 1991;34:461-70.
99. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 1992;358:414-7.
100. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994;372:786-91.
101. Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J Biol Chem 1994;269:26602-5.
102. Sato T, Tachibana K, Nojima Y, D'Avirro N, Morimoto C. Role of the VLA-4 molecule in T cell costimulation. J Immunol 1995;155:2938-47.
103. McCune JM. Viral latency in HIV disease. Cell 1995;82:183-8.
104. Schuitemaker H, Koot M, Kootstra NA, Dereksen MW, de Goede REY, van Steenwijk RP, et al. Biological phenotype of Human Immunodeficiency Virus Type 1 clones at different stages of infection: progression of disease is associated with a drift from monocytotropic to T-cell-tropic virus populations. J Virol 1992;66:1354-60.
105. Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM, Schellekens PT, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome obtained from studies on a panel of sequential HIV isolates. J Virol 1989;63:2118-25.
106. Gross W, Herberg U, Lehn M, Schneweis KE, Rolf R, Bialek R. Prognostic value of graded syncytium-induction of HIV-isolates in hemophilic children and adolescents. International Conference on AIDS 1993;1:296.
107. Vandenbrusaene M, Peeters M, Kestens L, Nys P, Colebunders R. Correlation between the prevalence of syncytium inducing (SI) HIV strains, clinical outcome and CD4 counts in HIV infected individuals. International Conference on AIDS 1993;1:554.
108. Koot M, van't Woudt A, Coutinho RA, Miedema F, Tersmette M, Schuitemaker H. Viral load in HIV-1 infected asymptomatic persons in relation with HIV-1 phenotype. International Conference on AIDS 1993;1:185.
109. Golding H, Dimitrov DS, Blumenthal R. LFA-1 adhesion molecules are not involved in the early stages of HIV-1 env-mediated cell membrane fusion. AIDS Res Hum Retroviruses 1992;8:1593-8.
110. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 1986;322:470-4.
111. Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
112. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, et al. CC CKR5: A Rantes, MIP-1 α, MIP-1 β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
113. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
114. Dorantz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW. A dualtropic primary HIV-1 isolate that uses fusin and the β-chemokines receptors CKR-5, CKR-3, and CKR-2b as fusion receptors. Cell 1996;85:1149-58.
115. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-71.
116. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994;6:865-74.
117. Ohgimoto S, Tabata N, Shigeru S, Nishio M, Ohta H, Tsurudome M, et al. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. J Immunol 1995;155:3585-92.
118. Ohta H, Tsurudome M, Matsumura H, Koga Y, Morikawa S, Kawano M, et al. Molecular and biological characterization of fusion regulatory proteins (FRPs): anti-FRP mAbs induced HIV-mediated cell fusion via the integrin system. EMBO J 1994;13:2044-55.
119. Pantaleo G, Butini L, Graziosi C, Poli G, Schnittman SM, Greenhouse JJ, et al. Human Immunodeficiency Virus infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission. J Exp Med 1991;173:511-4.
120. + T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science 1993;260:689-92.
121. FAK) in human T cells. J Exp Med 1995;182:2079-90.
122. Siegel JN, June CH, Yamada H, Rapp UR, Samelson LE. Rapid activation of c-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells. J Immunol 1993;151:4116-27.
123. Fraser JD, Straus D, Weiss A. Signal transduction events leading to T-cell lymphokine gene expression. Immunol Today 1993;14:357-62.
124. Song Z, Casalaro V, Chen R, Georas SN, Monos D, Ono SJ. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol 1996;156:424-9.
125. Genot EM, Parker PJ, Cantrell DA. Analysis of the role of protein kinase C-α, -ε, and ζ in T cell activation. J Biol Chem 1995;270:9833-9.
126. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
127. Collette Y, Chang HL, Cerdan C, Chambost H, Algarte M, Mawas C, et al. Specific Thl cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression. J Immunol 1996;156:360-70.
128. Henkart PA. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1994;1:343-6.
129. Silvestris F, Cafforio P, Frassanito MA, Tucci M, Romito A, Nagata S, et al. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS 1996;10:131-41.
130. Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler E, Autran B, et al. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HTV-specific cytotoxic T lymphocytes. Cell 1994;78:373-87.
131. Weissman D, Barker TD, Fauci AS. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 1996;183:687-92.
132. Kopelman RG, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988;8:82-8.
133. Morrow WJW, Isenberg DA, Sobol RE, Stricker RB, Kieber-Emmons T. AIDS virus infection and autoimmunity: a perspective of the clinical, immunological and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol 1991;58:163-80.
134. Kresina TF, Flanigan TP, Morrow WJW. Autoimmune manifestations in HIV disease: clinical and experimental aspects. In: Koff WC, Wong-Staal F, Kennedy RC, eds. AIDS Research Reviews. New York, Marcel Dekker Inc., 1992.
135. Bjork Jr. RL. HIV-1: seven facets of functional molecular mimicry. Immunol Letters 1991;28:91-5.
136. Naylor PH, Naylor CW, Badamchian M, Wada S, Goldstein AL, Wang SS, et al. Human immunodeficiency virus contains an epitope immunoreactive with thymosin α1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30. Proc Natl Acad Sci USA 1987;84:2951-5.
137. Solder B, Marschang P, Wachter H, Dierich MP, Nayyar S, Lewin IV, et al. Antiviral antibodies in HIV (HTLV-III) infection possess autoantibody activity against a CH1 domain determinant in human IgG: possible immunological consequences. Immunol Lett 1989;23:9-20.
138. Kieber-Emmons T, Jameson BA, Morrow WJW. The gp120-CD4 interface: structural, immunological and pathological implications. Biochimica Biophysica Acta, Reviews on Cancer series 1989;989:281-300.
139. Hohman AW, Booth K, Peters V, Gordon DL, Comacchio RM. Common epitope on HIV p24 and human platelets. Lancet 1993;342:1274-5.
140. Stricker RB, McHugh TM, Moody DJ, Morrow WJW, Stites DP, Shuman MA, et al. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ cells. Nature 1987;327:710-3.
141. Comacchio RM, Morrow WJW. Anti-lymphocyte antibodies in HIV infection: identification of a potential target antigen on CD4+ T cells. Immunology 1995;86 (suppl 1):118.
142. Williams WM, Whalley AS, Comacchio RM, Rosenberg J, Watts RA, Isenberg DA, et al. Anti-histone and antilymphocyte antibodies in patients with AIDS and HIV-related disorders. Clin Exp Immunol 1996;104:18-24.
143. Stricker RB, McHugh TM, Marx PA, Morrow WJW, Levy JA, Shuman MA, et al. Prevalence of an AIDS-related autoantibody against CD4+ T cells in humans and monkeys. Blood 1987;365(suppl 760):127A.
144. Fultz PN, Stricker RB, McClure HM, Anderson DC, Switzer WM, Horaist C. Humoral response to SIV/SMM infection in macaque and mangabey monkeys. J AIDS 1990;3:319-29.
145. Fultz PN, Siegel RL, Brodie A, Mawle AC, Stricker RB, Swenson RB, et al. Prolonged CD4(+) lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1. J Infect Dis 1991;163:441-7.
146. Argov S, Schattner A, Burstein R, Handzel ZT, Shoenfeld Y, Bentwich Z. Autoantibodies in male homosexuals and HIV infection. Immunol Letters 1991;30:31-6.
147. Warren RQ, Johnson EA, Donnelly RP, Lavia MF, Tsang KY. Specificity of anti-lymphocyte antibodies in sera from patients with AIDS-related complex (ARC) and healthy homosexuals. Clin Exp Immunol 1988;73:168-73.
148. Ziegler JL, Stites DP. Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol 1986;41:305-13.
149. Hoffmann GW, Kion TA, Forsyth RB, Soga KG, Cooper-Willis A. The N-dimensional network. In: Perelson AS, ed. Theoretical Immunology, Part Two, SFI Studies in the Sciences of Complexity. Addison-Wesley Publishing Company 1988:291-319.
150. Hoffmann GW, Grant MD. When HIV meets the immune system: network theory, alloimmunity, autoimmunity, and AIDS. In: Castillo-Chavez C, ed. Lecture Notes in Biomathematics, Vol 83, Mathematical and Statistical Approaches to AIDS Epidemiology. New York, Springer-Verlag 1989:386-405.
151. Hoffmann GW, Grant MD, Kion TA. A model for AIDS immunopathogenesis. Proc Natl Acad Sci USA 1991;88:3060-4.
152. Hoffmann GW. The T cell receptor and AIDS pathogenesis. Scand J Immunol 1995;41:331-7.
153. Kion TA, Hoffmann GW. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science 1991;253:1138-40.
154. del Guercio P, Zanetti M. The CD4 molecule, the human immunodeficiency virus and anti-idiotypic antibodies. Immunol Today 1987;8:204-5.
155. Chams V, Jouault T, Fenouillet E, Gluckman JC, Klatzmann D. Detection of anti-CD4 autoantibodies in the sera of HIV-infected patients using recombinant soluble CD4 molecules. AIDS 1988;2:353-61.
156. Thiriart C, Goudsmit J, Schellekens P, Barin F, Zagury D, De Wilde M, et al. Antibodies to soluble CD4 in HIV-1-infected individuals. AIDS 1988;2:345-51.
157. Sattentau QJ, Dalgleish AG, Weiss RA, Beverley PCL. Epitopes of the CD4 antigen and HIV infection. Science 1986;234:1120-3.
158. Wilks D, Walker LC, Habeshaw JA, Youle M, Gazzard B, Dalgleish AG. Anti-CD4 autoantibodies and screening for anti-idiotypic antibodies to anti-CD4 monoclonal antibodies in HIV-seropositive people. AIDS 1990;4:113-8.
159. Karpatkin S, Nardi M. Autoimmune anti-HIV-1 gp120 antibody and antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia. J Clin Invest 1992;89:356- 64.
160. Shearer GM. AIDS: An autoimmune pathologic model for the destruction of a subset of helper T lymphocytes. Mt Sinai J Med 1986;53:609-15.
161. Shearer GM, Bernstein DC, Tung KS, Via CS, Redfield R, Salahuddin SZ, et al. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 1986;137:2514-21.
162. Edelman AS, Zolla-Pazner S. AIDS: a syndrome of immune dysregulation, dysfunction, and deficiency. FASEB J 1989;3:22-30.
163. Habeshaw J, Hounsell E, Dalgleish A. Does the HIV envelope induce a chronic graft-versus-host-like disease? Immunol Today 1992;13:199-202.
164. Via CS, Shearer GM. T cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol Today 1988;9:207-13.
165. Shearer GM, Clerici M. How human immunodeficiency virus ravages the immune system. Curr Opin Immunol 1992;4:463-5.
166. Hounsell EF, Renouf DV, Liney D, Dalgleish AG, Habeshaw J. A proposed molecular model for the carboxy terminus of HIV-1 gp120 showing structural features consistent with the presence of a T-cell alloepitope. Molec Aspects Med 1991;12:283-96.
167. Golding H, Robey FA, Gates FT 3rd, Linder W, Beining PR, Hoffman T, et al. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II β1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med 1988;167:914-23.
168. Golding H, Shearer GM, Hillman K, Lucas P, Manischewitz J, Zajac RA, et al. Common epitope in human immunodeficiency virus (HIV)-1 gp41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV-1-infected individuals. J Clin Invest 1989;83:1430-5.
169. Young JA. HIV and HLA similarity. Nature 1988;333:215.
170. De La Barrera S, Fainboim L, Lugo S, Picchio GR, Muchinik GR, De Bracco MME. Anti-class II antibodies in AIDS patients and AIDS MSG groups. Immunology 1987;62:599-604.
171. Tyler DS, Nastala CL, Stanley SD, Matthews TJ, Lyerly HK, Bolognesi DP, et al. Gp120 specific cellular cytotoxicity in HIV-1 seropositive individuals.
172. Zagury JF, Bernard J, Achour A, Astgen A, Lachgar A, Fall L, et al. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis. Proc Natl Acad Sci USA 1993;90:7573-7.
173. Lopalco L, De Santis C, Meneveri R, Longhi R, Ginelli E, Grassi F, et al. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class 1 α1 peptide-binding domain. Eur J Immunol 1993;23:2016-21.